JAMIE PIERSON: Open Payments
NPI 1225751100 · MONTROSE, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,362 in 66 payments from 17 companies in 2025. Trend: 2023 $1,333 · 2024 $1,453 · 2025 $1,362
Food & beverage: $1,330Education: $32
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 9 | $408 |
| Novo Nordisk Inc | 17 | $247 |
| Amgen Inc. | 11 | $151 |
| Novartis Pharmaceuticals Corporation | 5 | $75 |
| Otsuka America Pharmaceutical, Inc. | 2 | $54 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $52 |
| Lilly USA, LLC | 3 | $51 |
| Axsome Therapeutics, Inc. | 2 | $46 |
| Aimmune Therapeutics, Inc. | 2 | $42 |
| ABBVIE INC. | 2 | $38 |
Products named: AIRSUPRA, OTEZLA, Ozempic, Wegovy, LEQVIO, Rybelsus, REXULTI, Kerendia.
Industry payments across MI — which companies pay providers there.
